| CONSOLIDATED REINSURANCE |
CONSOLIDATED REINSURANCE (in millions)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Column A | | Column B | | Column C | | Column D | | Column E | | Column F | | | | | Ceded | | Assumed | | | | Percentage | | | | | to | | from | | | | of Amount | | | Gross | | Other | | Other | | Net | | Assumed | | Description | | Amount | | Companies | | Companies | | Amount | | to Net | | | | | | | | | | | | | | As of or For the Year Ended December 31, 2024 | Individual life insurance in-force (1) | | $ | 2,068,962 | | | $ | 1,049,185 | | | $ | 5,742 | | | $ | 1,025,519 | | | 0.6 | % | | Premiums: | | | | | | | | | | | Annuities and life insurance (2) | | 10,610 | | | 2,387 | | | 83 | | | 8,306 | | | 1.0 | % | | Accident and health insurance | | 3,550 | | | 32 | | | 3 | | | 3,521 | | | 0.1 | % | | Total premiums | | $ | 14,160 | | | $ | 2,419 | | | $ | 86 | | | $ | 11,827 | | | | | | | | | | | | | | | | | As of or For the Year Ended December 31, 2023 | Individual life insurance in-force (1) | | $ | 2,094,011 | | | $ | 1,072,577 | | | $ | 6,024 | | | $ | 1,027,458 | | | 0.6 | % | | Premiums: | | | | | | | | | | | Annuities and life insurance (2) | | 10,369 | | | 4,700 | | | 86 | | | 5,755 | | | 1.5 | % | | Accident and health insurance | | 3,413 | | | 33 | | | 4 | | | 3,384 | | | 0.1 | % | | Total premiums | | $ | 13,782 | | | $ | 4,733 | | | $ | 90 | | | $ | 9,139 | | | | | | | | | | | | | | | | | As of or For the Year Ended December 31, 2022 | Individual life insurance in-force (1) | | $ | 2,028,279 | | | $ | 831,478 | | | $ | 6,512 | | | $ | 1,203,313 | | | 0.5 | % | | Premiums: | | | | | | | | | | | Annuities and life insurance (2) | | 10,365 | | | 1,981 | | | 94 | | | 8,477 | | | 1.1 | % | | Accident and health insurance | | 3,242 | | | 34 | | | 4 | | | 3,213 | | | 0.1 | % | | Total premiums | | $ | 13,607 | | | $ | 2,015 | | | $ | 98 | | | $ | 11,690 | | | |
(1) Includes Group Protection segment and Other Operations in-force amounts. (2) Includes insurance fees on universal life and other interest-sensitive products.
|